
SHIKARI® Q-AF
Enzyme immunoassay for the quantitative determination of Aflibercept (Eylea®) in human serum and plasma
Enzyme immunoassay for the quantitative determination of Aflibercept (Eylea®) in serum and plasma. The Matriks Biotek Shikari Aflibercept ELISA has been especially developed for the quantitative analysis of Aflibercept in serum and plasma samples.
Click the diagram to see bigger
Required Volume (µl) | 10 |
---|---|
Total Time (min) | 70 |
Sample | Serum, plasma |
Sample Number | 96 |
Detection Limit (ng/mL) | 30 |
Spike Recovery (%) | Between 85-115 |
Shelf Life (year) | 1 |